-
公开(公告)号：US10117988B2
公开(公告)日：2018-11-06
申请号：US14115363
申请日：2012-05-09
申请人： Vernon D. Ortenzi , John Edward Powers , Robert J. Ziemba , Rhonda J. Soest , Pamela L. Pollard
发明人： Vernon D. Ortenzi , John Edward Powers , Robert J. Ziemba , Rhonda J. Soest , Pamela L. Pollard
摘要： Contrast administration data that relates to operation of a contrast media injector system (602) may be converted from at least one format (e.g., a CAN-compliant format) to at least one other format (e.g., an HL-7-compliant format) for use by a medical system (600). Data on contrast media prescribed for an imaging operation using an imaging system (690), data on contrast media dispensed from a contrast media storage/dispensing unit (500) for use in this imaging operation, and data on contrast media actually administered/injected by a contrast media injector system (602) for this imaging operation may be stored in a data structure (780). Patient renal function data may be used to control the dispensing of contrast media from the contrast media/storage/dispensing unit (500), to control the operation of the contrast media injector system (602), or both, and may be stored in the data structure (780) as well.
-
公开(公告)号：US20120090278A1
公开(公告)日：2012-04-19
申请号：US13272904
申请日：2011-10-13
CPC分类号： A61F13/00076 , A61B50/37
摘要： Various embodiments of transdermal patch disposal devices are disclosed. Each such disposal device utilizes a containment having a patch disposal slot. A transdermal patch may be directed through this patch disposal slot for retention within an internal chamber of the containment. This patch disposal slot may be configured to reduce the potential of being able to withdraw a transdermal patch back out of the containment through the patch disposal slot. The interior of the containment may include one or more ribs which may reduce the potential of being able to withdraw a transdermal patch back out of the containment through the patch disposal slot.
摘要翻译： 公开了透皮贴剂处理装置的各种实施方案。 每个这样的处置装置利用具有补片处理槽的容纳物。 透皮贴剂可引导通过该补片处理槽，以保持在容纳物的内部室中。 该补片处理槽可以被配置为减少能够通过补片处理槽将透皮贴片从包容物中退出的潜力。 容纳物的内部可以包括一个或多个肋，其可以减少能够通过贴片处理槽从透气贴片返回出密封件的潜力。
-
公开(公告)号：US20110272426A1
公开(公告)日：2011-11-10
申请号：US13103234
申请日：2011-05-09
CPC分类号： B65D83/04 , A61J1/03 , A61J7/0076 , A61J7/04
摘要： Pharmaceutical product dispensers (e.g., in the shape of a common ink pen) are operable to indicate information regarding a dosing schedule of a pharmaceutical product dispensable from the dispenser. Embodiments of the dispensers may include a plurality of dosing segments, each corresponding to a different dose of the pharmaceutical product. Actuation of an actuator may result in interaction between the actuator and the pharmaceutical product storage area such that a dose of pharmaceutical product contained in the pharmaceutical product storage area is dispensed, along with a corresponding advancement of the plurality of dosing segments. The dispenser may also include one or more locks to prevent unauthorized access to the pharmaceutical product (e.g., by a child or the like). Furthermore, the pharmaceutical product dispenser may include a disabling mechanism to permanently disable actuation of the actuator of the dispenser.
摘要翻译： 医药产品分配器（例如，以普通墨水笔的形状）可操作以指示关于从分配器分配的药物产品的给药方案的信息。 分配器的实施例可以包括多个给药段，每个给药段对应于不同剂量的药物产品。 致动器的致动可能导致致动器和药物产品存储区域之间的相互作用，使得药物产品储存区域中包含的药物产品的剂量与多个给药段的相应进展一起被分配。 分配器还可以包括一个或多个锁，以防止未经授权地访问药品（例如由儿童等）。 此外，药品分配器可以包括禁用机构以永久地禁用分配器的致动器的致动。
-
公开(公告)号：US08925727B2
公开(公告)日：2015-01-06
申请号：US13014876
申请日：2011-01-27
CPC分类号： B65D5/00 , B65D2209/00
摘要： A transdermal patch container (10) that includes a container body (16), a first compartment (24), and a second compartment (28) is disclosed. One or more first transdermal patches (34) may be stored in the first compartment (24). One or more second transdermal patches (36) may be stored in the second compartment (28). The first transdermal patches (34) differ from the second transdermal patches (36) in at least one respect. A number of features may be incorporated to reduce the potential of being able to withdraw second transdermal patches (36) out of the second compartment (28). For instance, second transdermal patches (36) may be required to be directed through a slot (44) to enter a second compartment (28i). A flap (66) may be positioned below such a slot (58) within a second storage compartment (28ii). A plurality of vertically spaced or staggered flaps (96) may be positioned within a second storage compartment (28iv).
摘要翻译： 公开了一种包括容器主体（16），第一隔室（24）和第二隔室（28）的透皮贴片容器（10）。 一个或多个第一透皮贴片（34）可以存储在第一隔室（24）中。 一个或多个第二透皮贴片（36）可以存储在第二隔室（28）中。 在至少一个方面，第一透皮贴片（34）不同于第二透皮贴片（36）。 可以并入许多特征以减少能够将第二透皮贴片（36）从第二隔室（28）中取出的潜力。 例如，可能需要将第二透皮贴片（36）引导通过狭槽（44）以进入第二隔室（28i）。 翼片（66）可以定位在第二储藏室（28ii）内的这种狭槽（58）下方。 多个垂直间隔或交错的翼片（96）可以定位在第二储存隔间（28iv）内。
-
5.发明申请公开(公告)号：US20110272428A1
公开(公告)日：2011-11-10
申请号：US13103266
申请日：2011-05-09
IPC分类号： B65D83/04
CPC分类号： B09B3/0075 , A61J1/035 , B65B53/02 , B65D75/327 , B65D81/3446
摘要： A pharmaceutical product supply including primary packaging (e.g., a blister card) having a plurality of receptacles and pharmaceutical product (e.g., one or more pills, capsules, etc.) enclosed within at least one of the receptacles. Heating the pharmaceutical product supply to at least an activation temperature of a heat-activated encapsulation material associated with the supply may encapsulate the pharmaceutical product to reduce the likelihood that the pharmaceutical product can thereafter be administered, and thereby facilitates disposal of the pharmaceutical product. In one embodiment, a tray of a primary packaging is constructed of the heat-activated encapsulation material. In another embodiment, primary packaging may be disposed within a cavity of secondary packaging (e.g., carton), and the heat-activated encapsulation material may be in the form of a layer that is also located within the cavity.
摘要翻译： 包括具有多个容器的初级包装（例如，泡罩卡）和包封在至少一个容器内的药物产品（例如一个或多个药丸，胶囊等）的药物产品供应。 将药物产品供应加热至至少与供应物相关联的热活化包封材料的活化温度可封装药物产品以降低药物产品之后可能被施用的可能性，从而有利于药物产品的处置。 在一个实施例中，主要包装的托盘由热活化封装材料构成。 在另一个实施例中，初级包装可以设置在次级包装（例如，纸箱）的空腔内，并且热活化的包封材料可以是也位于空腔内的层的形式。
-
公开(公告)号：US20110225936A1
公开(公告)日：2011-09-22
申请号：US13014896
申请日：2011-01-27
CPC分类号： B65D50/04 , B65D50/06 , B65D2209/00
摘要： A container (100) for storing transdermal patches is disclosed. The container (100) includes a child-resistant mechanism (112) to reduce the likelihood of access to the transdermal patches (TP) by children. The child-resistant mechanism (112) may include first and second access components (116, 120) that may be disposed in a non-opposing manner and that may be in any appropriate form (e.g., buttons). Activation or engagement of the first and second access components (116, 120) in a particular manner allows the container (100) to assume an open configuration to access and/or load patches. In one arrangement, the first and second access components (116, 120) may be simultaneously engaged (e.g., depressed) to open the container (100). In another arrangement, the first and second access components (116, 120) may be engaged in series in a particular sequence to open the container (100).
摘要翻译： 公开了一种用于储存透皮贴剂的容器（100）。 容器（100）包括防儿童机构（112），以减少儿童进入经皮贴片（TP）的可能性。 防儿童机构（112）可以包括第一和第二访问部件（116,120），其可以以非相对的方式设置并且可以是任何适当的形式（例如按钮）。 以特定方式激活或接合第一和第二访问组件（116,120）允许容器（100）采取打开配置来访问和/或加载补丁。 在一种布置中，第一和第二进入部件（116,120）可以同时接合（例如，压下）以打开容器（100）。 在另一种布置中，第一和第二进入部件（116,120）可以以特定的顺序串联啮合以打开容器（100）。
-
公开(公告)号：US20110216627A1
公开(公告)日：2011-09-08
申请号：US13015223
申请日：2011-01-27
摘要： Systems and methods for tracking dosage periods are disclosed. The systems and methods may include setting a timer (140) to a predetermined value corresponding to a dosage period in response to the engagement of a cover (110) to a container (120). An indication may be provided that corresponds to a remaining period in the dosage period set by the engagement of the cover (110) and container (120). The indication may also indicate a remaining time period in the dosage period.
摘要翻译： 公开了跟踪剂量期的系统和方法。 系统和方法可以包括响应于盖（110）与容器（120）的接合而将定时器（140）设置为对应于剂量周期的预定值。 可以提供对应于通过盖（110）和容器（120）的接合设定的剂量期间中的剩余时间段的指示。 指示也可以指示剂量期间的剩余时间段。
-
公开(公告)号：US08910456B2
公开(公告)日：2014-12-16
申请号：US13014896
申请日：2011-01-27
CPC分类号： B65D50/04 , B65D50/06 , B65D2209/00
摘要： A container (100) for storing transdermal patches is disclosed. The container (100) includes a child-resistant mechanism (112) to reduce the likelihood of access to the transdermal patches (TP) by children. The child-resistant mechanism (112) may include first and second access components (116, 120) that may be disposed in a non-opposing manner and that may be in any appropriate form (e.g., buttons). Activation or engagement of the first and second access components (116, 120) in a particular manner allows the container (100) to assume an open configuration to access and/or load patches. In one arrangement, the first and second access components (116, 120) may be simultaneously engaged (e.g., depressed) to open the container (100). In another arrangement, the first and second access components (116, 120) may be engaged in series in a particular sequence to open the container (100).
摘要翻译： 公开了一种用于储存透皮贴剂的容器（100）。 容器（100）包括防儿童机构（112），以减少儿童进入经皮贴片（TP）的可能性。 防儿童机构（112）可以包括第一和第二访问部件（116,120），其可以以非相对的方式设置并且可以是任何适当的形式（例如按钮）。 以特定方式激活或接合第一和第二访问组件（116,120）允许容器（100）采取打开配置来访问和/或加载补丁。 在一种布置中，第一和第二进入部件（116,120）可以同时接合（例如，压下）以打开容器（100）。 在另一种布置中，第一和第二进入部件（116,120）可以以特定的顺序串联啮合以打开容器（100）。
-
公开(公告)号：US08842501B2
公开(公告)日：2014-09-23
申请号：US13015223
申请日：2011-01-27
摘要： Systems and methods for tracking dosage periods are disclosed. The systems and methods may include setting a timer (140) to a predetermined value corresponding to a dosage period in response to the engagement of a cover (110) to a container (120). An indication may be provided that corresponds to a remaining period in the dosage period set by the engagement of the cover (110) and container (120). The indication may also indicate a remaining time period in the dosage period.
摘要翻译： 公开了跟踪剂量期的系统和方法。 系统和方法可以包括响应于盖（110）与容器（120）的接合而将定时器（140）设置为对应于剂量周期的预定值。 可以提供对应于通过盖（110）和容器（120）的接合设定的剂量期间中的剩余时间段的指示。 指示也可以指示剂量期间的剩余时间段。
-
公开(公告)号：US08342331B2
公开(公告)日：2013-01-01
申请号：US13103247
申请日：2011-05-09
IPC分类号： B65D83/04
CPC分类号： A61J1/035 , B65D53/08 , B65D75/367 , B65D75/38 , B65D83/0463 , B65D2575/365
摘要： A pharmaceutical product supply is disclosed in the form of a container, a pharmaceutical product receiver, pharmaceutical product, an adhesive, and at least one release liner. The pharmaceutical product receiver includes a plurality of receptacles for pharmaceutical product. The container is initially disposed in a first configuration where all of the pharmaceutical product receiver receptacles may be accessible. The container is thereafter disposable in a second configuration where no covering for any of the pharmaceutical product receiver receptacles is accessible through any openable access incorporated by the container. One or more release liners may be moved to expose adhesive for disposing and retaining the container in its second configuration. The noted second configuration of the container facilitates disposal of the pharmaceutical product supply (e.g., now being in a form that should reduce the potential for gaining access to any remaining pharmaceutical product still enclosed within the pharmaceutical product receiver).
-
-
-
-
-
-
-
-
-
搜索结果
36 条记录 (耗时 0.025 秒)
